ATE289609T1 - Makrolid-lhrh-antagonisten - Google Patents

Makrolid-lhrh-antagonisten

Info

Publication number
ATE289609T1
ATE289609T1 AT99912259T AT99912259T ATE289609T1 AT E289609 T1 ATE289609 T1 AT E289609T1 AT 99912259 T AT99912259 T AT 99912259T AT 99912259 T AT99912259 T AT 99912259T AT E289609 T1 ATE289609 T1 AT E289609T1
Authority
AT
Austria
Prior art keywords
lhrh antagonists
macrolide
compounds
disclosed
antagonists
Prior art date
Application number
AT99912259T
Other languages
English (en)
Inventor
Daryl R Sauer
Fortuna Haviv
John Randolph
Nicholas A Mort
Christopher R Dalton
Milan Bruncko
Michele A Kaminski
Bradley W Crawford
Lisa Marie Frey
Jonathon Greer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE289609T1 publication Critical patent/ATE289609T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99912259T 1998-03-27 1999-03-11 Makrolid-lhrh-antagonisten ATE289609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/049,963 US5955440A (en) 1998-03-27 1998-03-27 Macrolide LHRH antagonists
PCT/US1999/004658 WO1999050275A2 (en) 1998-03-27 1999-03-11 Macrolide lhrh antagonists

Publications (1)

Publication Number Publication Date
ATE289609T1 true ATE289609T1 (de) 2005-03-15

Family

ID=21962689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912259T ATE289609T1 (de) 1998-03-27 1999-03-11 Makrolid-lhrh-antagonisten

Country Status (20)

Country Link
US (1) US5955440A (de)
EP (1) EP1066304B1 (de)
JP (1) JP2002509937A (de)
KR (1) KR20010034694A (de)
CN (1) CN1307584A (de)
AT (1) ATE289609T1 (de)
AU (1) AU3067499A (de)
BG (1) BG104844A (de)
BR (1) BR9909080A (de)
CA (1) CA2325521A1 (de)
DE (1) DE69923835T2 (de)
ES (1) ES2238828T3 (de)
HU (1) HUP0102011A3 (de)
IL (1) IL138219A0 (de)
NO (1) NO20004860L (de)
PL (1) PL348242A1 (de)
PT (1) PT1066304E (de)
SK (1) SK13972000A3 (de)
TR (1) TR200002767T2 (de)
WO (1) WO1999050275A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
KR20060002800A (ko) * 2003-03-05 2006-01-09 립-엑스 파마슈티칼즈, 인크. 이관능성 헤테로시클릭 화합물, 및 그의 제조 및 사용 방법
EP1682563A1 (de) * 2003-10-30 2006-07-26 Rib-X Pharmaceuticals, Inc. Bifunktionelle heterocyclische macrolidverbindungen und verfahren zu deren herstellung und anwendung
EP1699808A1 (de) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunktionelle heterocyclische macrolidverbindung und verfahren zu deren herstellung und deren anwendung
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
PL1836211T3 (pl) * 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy
WO2011018510A1 (en) * 2009-08-13 2011-02-17 Basilea Pharmaceutica Ag New macrolides and their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
DE3689758T2 (de) * 1985-08-31 1994-08-18 Kitasato Inst Erythromycinderivat und Verfahren zu dessen Herstellung.
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5403923A (en) * 1990-11-28 1995-04-04 Taisho Pharmaceutical Co., Ltd. 6-0-methylerythromycin A derivatives
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69620241T2 (de) * 1995-12-14 2002-10-02 MERCK & CO., INC. (A NEW JERSEY CORP.) Gonadotropin releasing hormon- antagonisten
AU726075B2 (en) * 1996-05-07 2000-10-26 Abbott Laboratories 6-o-substituted erythromycin compounds and method for making same

Also Published As

Publication number Publication date
AU3067499A (en) 1999-10-18
IL138219A0 (en) 2001-10-31
NO20004860D0 (no) 2000-09-27
TR200002767T2 (tr) 2001-05-21
JP2002509937A (ja) 2002-04-02
DE69923835T2 (de) 2006-04-06
HK1036284A1 (en) 2001-12-28
BR9909080A (pt) 2000-12-12
WO1999050275A2 (en) 1999-10-07
ES2238828T3 (es) 2005-09-01
KR20010034694A (ko) 2001-04-25
CA2325521A1 (en) 1999-10-07
WO1999050275A3 (en) 2001-02-22
PL348242A1 (en) 2002-05-20
US5955440A (en) 1999-09-21
PT1066304E (pt) 2005-06-30
HUP0102011A3 (en) 2003-07-28
DE69923835D1 (de) 2005-03-31
BG104844A (en) 2001-07-31
EP1066304A1 (de) 2001-01-10
HUP0102011A2 (hu) 2001-11-28
SK13972000A3 (sk) 2001-07-10
NO20004860L (no) 2000-11-24
EP1066304B1 (de) 2005-02-23
CN1307584A (zh) 2001-08-08

Similar Documents

Publication Publication Date Title
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
IL137332A (en) Benzothiadiazoles and derivatives, their preparation and pharmaceutical compositions comprising them
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
DE69923835D1 (de) Makrolid-lhrh-antagonisten
HUP0200363A2 (en) Lhrh antagonist decapeptides, pharmaceutical compositions comprising thereof and processes for their preparation
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
NZ506622A (en) 3',3'-N-bis-substituted macrolide LHRH antagonists
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
EP1059304A4 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
FR2783521B1 (fr) Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
EP1221945A4 (de) Verfahren sowie pharmazeutische und therapeutische zusammensetzungen zur verabreichung von adenosin
HUP0103212A3 (en) 2-oxo-2h-quinoline derivatives, pharmaceutical compositions containing them and processes for their preparation
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1066304

Country of ref document: EP

REN Ceased due to non-payment of the annual fee